祥生医疗
(688358)
| 流通市值：31.61亿 | | | 总市值：31.65亿 |
| 流通股本：1.12亿 | | | 总股本：1.12亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 241,448,492.64 | 127,282,003.17 | 435,809,891.23 | 343,166,004.6 |
| 营业总成本 | 180,385,311.28 | 87,572,600.8 | 321,427,284.76 | 244,789,561.66 |
| 其他经营收益 | | | | |
| 营业利润 | 71,651,279.97 | 48,368,212.44 | 126,943,299.23 | 106,040,897.9 |
| 利润总额 | 76,919,006.87 | 50,124,790.77 | 128,647,523.71 | 105,252,978.25 |
| 净利润 | 68,957,612.85 | 46,026,273.65 | 116,499,752.06 | 93,920,462.46 |
| 每股收益 | | | | |
| 其他综合收益 | -20,178,612.36 | -10,339,696.43 | -13,411,702.03 | -4,277,383.19 |
| 综合收益总额 | 48,779,000.49 | 35,686,577.22 | 103,088,050.03 | 89,643,079.27 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,409,956,497.89 | 1,384,549,675.14 | 1,406,616,826.11 | 1,384,870,679.88 |
| 非流动资产: | | | | |
| 非流动资产合计 | 192,474,375.91 | 189,492,074.28 | 188,306,116.11 | 192,477,128.19 |
| 资产总计 | 1,602,430,873.8 | 1,574,041,749.42 | 1,594,922,942.22 | 1,577,347,808.07 |
| 流动负债: | | | | |
| 流动负债合计 | 214,132,317.14 | 135,678,760.7 | 195,993,791.3 | 168,523,205.02 |
| 非流动负债: | | | | |
| 非流动负债合计 | 20,254,144.96 | 18,761,893.44 | 15,440,444.69 | 8,717,322.03 |
| 负债合计 | 234,386,462.1 | 154,440,654.14 | 211,434,235.99 | 177,240,527.05 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,368,044,411.7 | 1,419,601,095.28 | 1,383,488,706.23 | 1,400,107,281.02 |
| 股东权益合计 | 1,368,044,411.7 | 1,419,601,095.28 | 1,383,488,706.23 | 1,400,107,281.02 |
| 负债和股东权益合计 | 1,602,430,873.8 | 1,574,041,749.42 | 1,594,922,942.22 | 1,577,347,808.07 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 265,886,473.65 | 112,317,767.1 | 501,863,306.77 | 374,078,230.83 |
| 经营活动现金流出小计 | 229,707,386.36 | 129,223,517.11 | 394,695,103.91 | 300,787,947.92 |
| 经营活动产生的现金流量净额 | 36,179,087.29 | -16,905,750.01 | 107,168,202.86 | 73,290,282.91 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 448,890,030.77 | 202,069,046.29 | 1,531,590,335.88 | 1,290,963,822.17 |
| 投资活动现金流出小计 | 502,621,852.06 | 74,647,935.44 | 1,473,766,976.91 | 1,263,296,346.91 |
| 投资活动产生的现金流量净额 | -53,731,821.29 | 127,421,110.85 | 57,823,358.97 | 27,667,475.26 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 3,735,750 | - |
| 筹资活动现金流出小计 | 34,802,919.24 | 34,111,537.69 | 116,273,752.67 | 115,991,387.67 |
| 筹资活动产生的现金流量净额 | -34,802,919.24 | -34,111,537.69 | -112,538,002.67 | -115,991,387.67 |
| 汇率变动对现金及现金等价物的影响 | -22,018,896.19 | -12,966,786.29 | -30,544,053.35 | -4,939,828.76 |
| 现金及现金等价物净增加额 | -74,374,549.43 | 63,437,036.86 | 21,909,505.81 | -19,973,458.26 |
| 期末现金及现金等价物余额 | 766,198,278.43 | 904,009,864.72 | 840,572,827.86 | 798,730,377.81 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -74,374,549.43 | - | 21,909,505.81 | - |
最新报告期：2026-09-01| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 太平洋 | 谭紫媚 | 1.18 | 1.45 | 1.70 | 2026-09-01 |
| 国信证券 | 凌珑,彭思宇,陈曦炳 | 1.22 | 1.56 | 1.72 | 2026-08-31 |